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Summary: 
This thesis addresses the question of how to measure and reduce environmental impacts from logistics 
activities. Therefore, a measurement framework for the most relevant environmental factors - CO2 emissions, 
waste production, and energy consumption - is developed and then applied in a case study to a 
pharmaceutical company. 
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KEY INSIGHTS 
1. Air transportation is the driving factor in the CO2 
emissions from transportation. This can be 
addressed through mode shift. Other reduction 
activities include increased capacity utilization 
and fuel efficiency for truck transportation. 
2. Collaboration regarding warehousing and 
temperature regulation methods minimizes 
material use and disposal in a company’s 
logistics chain.  
 
 
Introduction 
Nowadays, companies are facing increased pressure 
from a broad group of stakeholders to minimize their 
environmental impact:  
Governments are increasing environmental 
regulations related to waste as well as emissions, 
forcing companies to rethink their processes in order 
to prevent fees and penalties. Moreover, increasing 
pressure from customers and the public, which poses 
greater awareness concerning environmental issues, 
also has to be taken into account. Additionally, 
because of increasing raw material and oil prices, a 
reduction of environmental impact is usually related 
to significant cost reducing goals. 
 
At the same time, globalization of sourcing, 
manufacturing, as well as marketing of products, has 
extended the reach of supply chains and increased 
the need for global transportation and warehousing. 
These increased logistics activities cause multiple 
impacts on the environment, namely CO2 emissions 
from transportation actions as well as waste 
production and energy consumption from 
warehousing activities. 
  
Because of the constant growth of such global 
logistics activities, a need emerges to manage the 
environmental impacts from logistics activities. 
However, to begin to manage the environmental 
impact of a company’s global logistics activities, it is 
first necessary to measure it. It is therefore crucial for 
a company to clearly understand the source and 
quantity of its environmental impact and track it over 
time. 
Therefore, a framework for the measurement of each 
of the named factors will be defined in this work and 
then applied in a case study to a pharmaceutical 
company’s distribution activities. Distribution in this 
context is understood as the storage and movement 
of finished goods from the destination warehouse to 
local warehouses. Consequently, production and 
packaging activities are not included in the case 
study, nor are distribution to and waste at the final 
customer. 
After determining the current CO2 emissions, waste 
production volume, and energy consumption, 
recommendations for reductions of these factors are 
given and quantified. 
Case Study Background 
The company profiled in this study is a major 
pharmaceutical company based in Europe. The 
central warehouse and packaging facilities are 
located in Europe and they serve about 40 markets 
across the world. The company is committed to 
developing and introducing new products to the 
market, and invests heavily in research and 
development. Their primary focus is on producing 
branded, nongeneric medicines that are sold under 
patent protection. In addition, most of their goods are 
cold-chain products that require temperature 
regulation transportation and warehousing 
conditions. Due to strict quality standards and tight 
regulatory guidelines, the supply chain of this 
company is faced with short lead times, high levels of 
inventory, and stochastic demand for certain 
products. The high value density of the products also 
places additional pressure on the supply chain to 
protect the pharmaceuticals from pilferage and 
tampering. These are factors that must be 
considered when evaluating current and potential 
logistics scenarios. 
In order to determine the environmental impacts of 
the company analyzed, it was decided to employ the 
methodologies presented by the Greenhouse Gas 
Protocol (WRI and WBCSD, 2004) and by the 
Chartered Institute of Management Accountants 
(2002) for all calculations performed. 
Environmental Impacts from Logistics Activities 
The analysis of the data yields the result as seen in 
the following table: 
 Annual Environmental Impact
CO2 Emissions 50,000 t 
Solid Waste 
Disposal 68,000 t 
Energy 
Consumption 38.6 mil kWh
Regarding the CO2 emissions, the analysis showed 
that around 95% of the emissions are caused by air 
transportation, while only around 5% of the 
emissions are caused by road transportation. Other 
modes of transportation play no significant role. It 
also showed that the vehicle capacity utilization, 
especially in trucks, is usually low.  
Because of the high share of emissions resulting 
from air transportation, a shift from air to other modes 
of transport offers the biggest potential for reduction 
options. However, it might also be one of the most 
complex ones to implement. The longer lead times 
require more inventory in transit as well as an 
increased safety inventory at the destination 
warehouse. Additionally, it has to be taken into 
account that other issues like lead time reliability, 
product value, shrinkage, or product safety in general 
have a significant impact on cost and risk of a mode 
shift from air to sea transportation. 
Another possibility that could also significantly 
influence emissions is the improvement of the 
utilization of vehicle space. Better capacity utilization, 
by keeping the freight volume constant, means that 
less trips are needed, which leads to less CO2 
emissions. This could be achieved by either sending 
larger shipments less frequently, pooling shipments, 
or by redesigning product packaging in order to make 
it more dense. However, because of the high value 
density of pharmaceutical products, security issues 
like insurance limits for the total value in a shipment, 
have to be kept in mind. 
A different option could be to increase the fuel 
efficiency of trucks, leading to lower fuel consumption 
for the same transportation performance. Research 
showed that basic measures such as properly 
inflating tires or training drivers in fuel efficient 
behavior might have a significant impact. However, 
because of the relatively small share of this mode of 
transportation in total emissions, the results on total 
emissions of all this measures remain rather limited. 
For the solid waste analysis, each waste product is 
analyzed by the volume generated (see table below) 
and the environmental implications. Even though 
wood is the smallest component of the entire waste 
stream, it represents a material that could be 
completely avoided by introducing a plastic pallet 
system into this segment of the supply chain, 
resulting in an annual savings of over 1 million Euros. 
 
 
Waste Material  
Annual Tons 
Generated 
Corrugated Fiberboard 34000
Plastic 17860
Paper 7000
Styrofoam 4760
Wood 4350
Total 67970
In contrast, corrugated fiberboard comprised almost 
half of the entire tonnage of the waste stream, 
resulting from passive cooling containers used to 
regulate the temperature of the product. The disposal 
of these goods could be addressed simply by 
communication and collaboration of the different 
stages of the supply chain. Instead of disposing of 
these containers at the first destination, they can 
easily be reused further down the supply chain by 
local distributors and primary customers. Other waste 
streams, specifically plastic wrap and styrofoam, 
could also be significantly reduced by greater 
communication and collaboration about the use and 
utility of certain materials, and how these can be 
extended beyond its first destination. Also, the 
inherent value of the waste generated can create 
logistics operations that are amenable to reselling 
these materials to avoid disposal costs and possibly 
gain additional revenue streams. 
In relation to energy consumption, the data collected 
indicated the total amount of energy being consumed 
to operate the central warehouse in Europe and the 
40 regional warehouses in the logistics network. Until 
the company can identify specific functions of the 
warehousing operations and allocate certain energy 
flows to these operations, determining specific 
reduction strategies remains difficult. However, 
based on site visits and discussions with logistics 
providers, the main source of energy consumption 
was the direct cooling of goods through refrigeration, 
even though this method was often combined with 
other temperature regulation mechanisms. Due to 
the sensitive nature of pharmaceutical products, it is 
not recommended that these policies be modified 
unless more detailed data that specifies the cooling 
methods used at each facility individually become 
available.  
The table below summarizes the complexity and 
impact of the discussed measures aimed at reducing 
emissions and waste. 
 
 
 
Area of 
Reduction 
Measure Complexity Impact
CO2 
Emissions Mode Shift 
high high
 Increased 
load factor 
mid mid
 Increased 
fuel 
efficiency 
low low
Solid Waste 
Disposal 
Extend life 
of cooling 
containers 
low high
 Plastic 
Pallets 
mid mid
 
Implications 
Pharmaceutical companies can use the information 
from this case to measure, manage, and possibly 
minimize the environmental impacts of their logistics 
and distribution functions. For further actions, it might 
be helpful to collect further-reaching data and also 
standardize the data collected as well as the data 
collection process. Another possible action could be 
to extend the scope of the study. Although this study 
extends only to the regional warehouses, it could be 
expanded to include environmental impacts of the 
supply chain downstream of this point. For example, 
this analysis would be more robust if it included the 
transportation from the regional warehouses to 
consumers and the waste generated from the actual 
consumption of the goods. However, the scope of 
this study does allow pharmaceutical companies to 
understand the magnitude and nature of the 
environmental impacts over which they have greater 
control and influence. Testing the reduction 
strategies within this scope makes it easier for them 
to understand how to minimize environmental impact. 
This information can then be passed down to other 
entities in the supply chain, and the pharmaceutical 
company can assume a more active role in helping to 
manage those impacts for activities further removed 
from direct company operations. 
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